Visiting Korean Company

Each Korean Medical Company serves the CERTIFICATE OF PARTICIPATION and MEMORIAL PHOTO.

* This program is for foreigners only.
Company Name WONTECH
Website http://www.wtlaser.com/
Address

B-3rd Floor, Global R&D Center, 22, Daewangpangyo-ro

712beon-gil, Bundang-gu, Seongnam-si,

Gyeonggi-do, Korea

Postal Code 13488

Company Description

WONTECH, History of Korean Medical Laser Industry.

We are now leaping into a global leader in laser medical devices.

WONTECH has been concentrating on medical lasers for nearly 20 years. Increasing the quality of life via constant challenge and innovation, as a company providing healthy solutions to human beings, WONTECH has been listed in a world-class 300. Beyond a company in a world-class 300, we plan to be a hidden champion as a global brand.

WONTECH Co., Ltd. established in 1999, grows up steadily and leads a medical laser equipment & Ultrasound (HIFU) market.

Particularly, WONTECH realized a limitation of domestic techniques, which depend mostly on foreign technology when its establishment, invests continuously to achieve localization and development of techniques by composing 50% of employees in R&D. Based on our technical power and high tech facilities, WONTECH has expanded the market into not only Domestics, but also China, America, Europe, Middle East and other overseas market, continuing to enhance the global outstanding corporation.

With an advanced techniques, WONTECH’s equipment are facilitated in a variety of area including Skin Aesthetics, Fat Reduction, Surgical usage and still research and develop devices using Laser and Ultra sound to approach human health promotion in advance.

WONTECH will continuously improve all process from research, development to manufacturing and A/S of all our products with professional technology and developments to provide the best value.

To keep constant technical innovation, transparent management system and social responsibility, WONTECH has kept ties with regional society and will put efforts on standing as a Global Leader in worldwide.

Thank you.

Product Description

WONTECH is the world’s first company manufactures both Nd:YAG and Alexandrite Picosecond Laser.

Picosecond Laser is the one all Aesthetic Medical Laser companies competing for World’s first, WONTECH has developed Nd:YAG and even Alexandrite as well.

The most strict US FDA has admitted PICOCARE of WONTECH From hometown of laser, the biggest aesthetic medical market America, PICOCARE cleared FDA It is Asia’s first, and just few world widely.

 

“Leader of Pico Laser, WONTECH”

PICO BROTHERS
PICOCARE
  • Output : 600mJ / Pulse Duration : 750ps, 450ps
  • Realization of more than 5 different wavelengths
  • Compact size & Mobility
    (80kg – Compared to others, 120kg~170kg)
  • Real time energy compensation output during use & feedback
  • Applied energy compensation before and after conventional use
PICOWON
  • KOREA’s first Picosecond Alexandrite
  • Realization of Highest output of more than 400mJ
  • Adjustable output energy
  • Excellent Beam Profile
  • Implementation of high repeat rate
 
Company Name MEDYTOX
Website http://www.medytox.com/
Address

8~10F, 626, Teheran-ro,

Gangnam-gu,

Seoul, Korea

Postal Code 06172

Company Description

Medytox, a global biopharmaceutical company, is at the forefront of efforts to build a better future with ceaseless R&D.

Since the launch of botulinum toxin type A Meditoxin® in 2006 (trade name: Neuronox®, Siax®, Botulift®, Cunox®, Acebloc® and Meditoxin®), Medytox has shown a dramatic growth. Medytox reached nearly 40% of market share in Korea since 2009 and is expected to increase even further with various indications being included. The global botulinum toxin market continues to grow and is expected to further expand to not only medical aesthetics market but also therapeutic market. Medytox is stunning the world with high market share in the global botulinum market.

With the goal of penetrating to the US and Europe, we plan to exceed 10% of the market share in the global market along with the launch of the currently developing new type botulinum toxin products.

In the future, Medytox will grow as the leader of the biopharmaceutical industry by challenging ourselves with passion for the global market.

Product Description

[Neuronox®]

Neuronox® is Korea’s first and the fourth botulinum toxin type A product in the world, launched in 2006.

Neuronox® is a representative botulinum toxin type A product of Medytox that is being exported to over 60 countries. Neuronox® ranks No.1 in market share in Korea and has gained significant market share in many other countries. (Being sold worldwide under different brand names including Siax®, Botulift®, Cunox®, Tonytox® and Meditoxin®)

Neuronox® offers choices by providing a range of product units including 50, 100, 150 and 200.

Neuronox® Backed up by efficacy and safety proven through clinical trials, Neuronox® has recently reached the sales of over 1,200 million vials*, and the sales is still steadily growing.

*Figures from Medytox. (2018.11)


[INNOTOX®]

INNOTOX® is the world’s first liquid formulation of botulinum toxin type A product, develped and launched in 2014.

INNOTOX® is an innovative product which has been developed by totally excluding animal-derived ingredients and human serum albumin in order to enhance product safety. At the same time, it is easy to prepare since no dilution is necessary for adminisration. Currently INNOTOX® is being sold in Korea and Japan and it is emerging as the product to show our distinguished R&d capabilities.


[Coretox®]

Medytox has obtained Coretox® marketing approval in 2016, which was developed as the 3rd botulinum toxin type A product for the company. Coretox® is an advanced new botulinum toxin type A product that excludes animal derivatives, human serum albumin and non-toxin proteins from its ingredients. It prevents the immune system from developing antibodies that would eventually wear down the effects of botulinum toxin type A.


[Neuramis®]

Neuramis® is the hyaluronic acid dermal filler product developed and launched in 2011. The Neuramis® series Neuramis® Meso(Export Only), Neuramis® Light Lidocaine, Neuramis® Lidocaine, Neuramis® Deep, Neuramis® Deep

Lidocaine, Neuramis® Volume Lidocaine which can be used to add volume and fullness to the skin to correct moderate to severe nasolabial folds, the lines from your nose to the corners of your mouth.

Program Proposal

Medytox Company Tour

Medytox is a global Biopharmaceutical Company in Republic of Korea and we prepare Medytox Company Tour to give you a great experience.

Our tour will provide you with the useful information; regarding Neuronox (lyophilized powder) and Innotox (liquid), which are Botulinum toxin Type A products, and Neuramis Series, which is Hyaluroniuc acid filler.

Also, the Speech and Live Demonstration to make you improve your dermatological techniques are prepared.

[Detail Schedule]

  • PM 4:00~5:00 Pick-up from Hotel & move to Medytox (Seoul Office)
  • PM 5:10~5:20 Company Introduction Presentation
  • PM 5:20~5:50 Introduction of Neuronox® and Neuramis®
  • PM 6:00~7:30 Welcome Dinner

* 20 attendees only

 
Company Name LUTRONIC
Website https://int.lutronic.com/intl/
Address

219 Sowon-ro, Deogyang-gu, Goyang-si, Gyeonggi-do, Korea

Postal Code 110534

Company Description

ABOUT LUTRONIC

LUTRONIC, a leading innovator in advanced aesthetic and medical laser and related technology, was established in 1997 to bring intuitive, robust, versatile devices that are affordable and efficacious to the worldwide medical community. Committed to improving medicine, LUTRONIC partners with key opinion leaders to advance science and ensure the efficacy of its systems. All systems are versatile and offer multiple settings and treatment options for customized treatments, which maximize outcomes for a wide variety of conditions and treatments including: melasma, tattoo removal, soft tissue incision, vascular lesions, hair removal, wrinkle reduction, rejuvenation, body/face contouring, chronic pain, healing and more.

With a focus on physician needs and patient outcomes, LUTRONIC dedicates time and funding toward the development of devices that offer features and improvements not found in today’s market. Devoting more than 20% of revenue to R&D, LUTRONIC holds more than 130 current and pending patents worldwide. With more than 400 employees worldwide, LUTRONIC has offices in the Korea, US, China, Japan, Germany, and France, a worldwide network of distributors, focused R&D centers in both the US and Korea, and is ever expanding.

MISSION STATEMENT

Our passion is to improve the lives of physicians and their patients by developing innovative solutions that are intuitive, versatile, efficacious and beneficial to society.

Product Description

  1. Power and Versatility for Advanced Treatments and Mastery Over Difficult Cases.
    • High energy output 800 mJ(1.8 GW peak power) while still providing stable low energy output.
    • Dual pulse mode of Pico(450 ps) and Nano-second(2 ns).
    • Four wavelengths for best versatility.
    • Wide-range of precisely controllable fluence options.
    • 6 handpieces (including 2 type factional handpieces)
    • Convenience features, such as built-in storage.
    • More lighter convenient New S-Arm.
  2. PicoPlus premier laser safely treats melasma and beyond.
    • The number one maker of Nd:YAG technology is delivering the next evolution of premium platforms to your clinic.
    • PicoPlus is proven safe and effective for the treatment of melasma. It has the range of pulse width, power and wavelengths to allow you power over even the most difficult cases.
  3. Provide the Results your Patients Demand.
    • PicoPlus provides the treatment versatility, precise fluence and pulse control needed to achieve the results your patients want, regardless of difficulty.
    • Broad Range of Applications for Improved ROI.
Specialty Treatments Applications Applications Cont.
  • Pico Toning
  • Tattoo Removal
  • Gold Toning
  • Ruvy Touch
  • Focused Toning
  • Dual Focused Toning
  • Tattoo(Multi-colored & black)
  • Skin Rejuvenation (Cold Rejuvenation) including:

    • Wrinkle and Acne scars

    • Pores
  • Pigmentary issues such as:
    • Melasma

    • PIH
    • Nevus of Ota
    • ABNOM

    • Lentigo

    • Freckles

    • Seborrheic Keratosis

    • Café-au-lait
  • Redness issues such as:

    • Post-acne Erythema
    • Inflammatory Acne

    • Telangiectasia

    • Facial Flushing

    • Rosacea

Program Proposal

  • PM 4:00~4:30 Opening & Greeting
  • PM 4:30~5:30 Manufacturing Tour
  • PM 5:30~6:30 Product Presentation
  • PM 6:30~8:00 Dinner & Networking
 
Company Name Daewoong Pharmaceutical
Website http://www.daewoong.com
Address

Bongeunsa-ro114-gil 12,

Gangnam-gu,

Seoul, Korea

Postal Code 06170

Company Description

COMPANY OVERVIEW

Daewoong Group is a global healthcare group established in 1945 under the vision to ‘manufacture high quality pharmaceuticals to enhance people’s health and create a healthy society’.

As it is our vision to be a global healthcare group, Daewoong has established 3 manufacturing sites in Indonesia and China and 8 branch offices in China, Japan, Indonesia, Thailand, Vietnam, Philippines, India and USA. Through our global presence, we are actively striving to export our high value added portfolio to the world.

To achieve our mission to provide the most beneficial total solutions in pharmaceuticals and services that contribute to improving the quality of life of valued consumers, we have been reinforcing R&D capacities through the establishment of R&D centers globally in Korea, China, India and Indonesia and focusing on developing new chemical entities, biologics, incrementally modified drugs and high-value added APIs.

Strategy

Global Talent Platform Development
  • Global human resources development programs.
  • Foreign student scholarships.
  • Foreign medical student training.
  • ERP/CRM system establishment.
R&D and Manufacturing Reinforcement
  • Established Bio-Mecca (production site and R&D) in Indonesia.
  • Open collaboration between factory and R&D center in Liaoning, China.
  • Open collaboration opportunities of R&D for various type of drugs.
  • Research and develop CNS drugs in India R&D center.
  • High level of manufacturing capacity (Total 7 manufacturing sites overseas).
  • Reinforcement of production capabilities in US, EU, VN.
Global Business Expansion
  • Expanding into emerging markets (CIS, MENA, LATAM).
  • Diversifying business models for licensing out (FDF, Semi-FDF, API).
  • Reinforcing open-collaboration.
  • Expanding CDMO business to US and Japan (depot, differentiated formulation).
Strengthening Brand Awareness
  • Conducting various marketing activities to meet the needs of customers.
  • Global academic exchange and networking through global symposiums.
  • Academic support through local symposiums.
  • Promotion of products at local congresses and customer management.

Specialized Manufacturing Sites

Daewoong Pharmaceutical has a number of strategically located manufacturing sites, each of which specializes in various production lines such as depot injection, liquid suspension, biological, and etc.

By achieving global standards, the new cGMP facility will play a crucial role in establishing Daewoong Pharmaceutical as a leading global manufacturer to the worldwide market.

International Certificates.

Daewoong has manufactured numerous products launched from global pharmaceutical companies such as Novatis, Sanofi, Abbott and Recipharm. We’ve been proven by their quality assurance based on regular inspections from the products' originators.

Daewoong received the Excellent Manufacturer Award by Korean Quality Management and the President Award by the Korea Standards Association. Daewoong Observes International Environmental, Safety, and Health Standards. (ISO14001 and OHSAS18001 certificates).

High Quality Assurance Daewoong

  1. Manages cGMP level facilities through advanced automated system such as MES, QMS and EMS.
  2. Ensures Closed System in order to minimize cross contamination.
  3. Achieved high efficiency through the VTS(Vertical Transfer System).
  4. Runs 24hr monitoring IT system based on IOT to achieve our innovative manufacturing model.

Product Description

Nabota

Product Name
NABOTA®
Company Name
Daewoong Pharmaceutical Co., Ltd.
[ Active Ingredients ]
Prabotulinumtoxin A, 50 / 100 / 150 / 200 Units
(Clostridium botulinum toxin type A)
[ Indications & Usage ]
  1. Temporary improvement in the appearance of moderate to severe glabellar lines(vertical lines between the eyebrows) associated with corrugator muscle and/or procerus muscle activities, in adults aged between 20 to 65.
  2. Upper limb spasticity related to stroke in adults over 18years of age.
[ Package ]
10vials / Box

Characteristics

Patented Technology NABOTA was developed with Daewoong’s 30 years of experience in biotechnology. NABOTA ensures the quality of international standards via its own patented purification process. Patent registration KR 10-1339349(Patented in 2013). Reduced Impurity NABOTA is a highly purified product manufactured with a patented purification process from which impurities are removed as much as possible. Overseas Expansion Excellence in the quality of NABOTA has led to contracts to export the finished product to about 75 countries including the United States and 28 European countries. Active Ingredients Prabotulinumtoxin A, 50 / 100 / 150 / 200 Units (Clostridium botulinum toxin type A). Indications & Usage Temporary improvement in the appearance of moderate to severe glabellar lines(vertical lines between the eyebrows) associated with corrugator muscle and/or procerus muscle activities, in adults aged between 20 to 65. Upper limb spasticity related to stroke in adults over 18 years of age.

Program Proposal

  • PM 4:00 Hotel Pick-up
  • PM 5:30 Arrival at NABOTA factory
    (Hyangnam Factory, The first cGMP approved factory for Botulinum Toxin type A)
  • PM 5:40 ~ 6:10 Introduction of NABOTA factory
  • PM 6:00 ~ 7:10 Start NABOTA factory tour
    1. Logistics Area : warehousing, release and storage of law materials and MSB/WCB
    2. Cell Bank/Drug Substance Storage : Storage of cell bank and drug substance
    3. Finished Product Storage : Storage of finished product(NABOTA)
    4. Receipt& Release room : receipt and release of law materials and finished products
    5. Packaging Material Storage-1 : storage of packaging materials
    6. Packaging Material Storage-2 : storage of packaging materials and labeling materials
  • PM 7:20 Depart to hotel
  • PM 9:00 Arrival at hotel
 

Our Proud Sponsors